About
HT-ADVANCE develops multi-omics biomarker-based solutions for the diagnosis and personalized treatment of arterial hypertension to improve patient outcomes and reduce cardiovascular complications.
Explore HT-ADVANCE's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.